Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet activating factor Acetylhydrolase, is an inflammatory enzyme that circulates bound mainly to low density lipoproteins and has been found to be localized and enriched in atherosclerotic plaques.
In multiple clinical trials, Lp-PLA2 activity has been shown to be an independent predictor of coronary heart disease and stroke in the general population. Measurement of Lp-PLA2 may be used along with traditional cardiovascular risk factor measures for identifying individuals at higher risk of cardiovascular disease events.
Expect results in approximately 5 business days.
Preparation: Fasting is preferred, but not required. If fasting, abstain from food and non-water drinks for 10 hours prior to your blood draw.
Please be advised that our services are strictly self-pay and not eligible for submission as a claim to your health insurance provider, medical bill sharing company, Medicare/Medicaid or other third party payor. Quest code 94267.